25532946 35293336 24898046 22211313 22661552 20132066 19589891 26155108 29686436 24113730 21502697 28550389 - Search Results

Year	Number of Results
2009	1
2010	1
2011	1
2012	2
2013	1
2014	3
2015	1
2017	1
2018	1
2022	1
2023	0

1

Safety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions.

Abasolo L, Leon L, Rodriguez-Rodriguez L, Tobias A, Rosales Z, Maria Leal J, Castaño V, Vadillo C, Macarron P, Fontsere O, Jover JA. Abasolo L, et al. Semin Arthritis Rheum. 2015 Apr;44(5):506-513. doi: 10.1016/j.semarthrit.2014.11.003. Epub 2014 Nov 18. Semin Arthritis Rheum. 2015. PMID: 25532946

2

Presence of Autoantibodies in Males and Females With Rheumatoid Arthritis: A Systematic Review and Metaanalysis.

Hadwen B, Yu R, Cairns E, Barra L. Hadwen B, et al. J Rheumatol. 2022 Jul;49(7):663-671. doi: 10.3899/jrheum.211020. Epub 2022 Mar 15. J Rheumatol. 2022. PMID: 35293336

3

Comparison of characteristics of international and national databases for rheumatoid arthritis: a systematic literature review.

Gvozdenović E, Koevoets R, Langenhoff J, Allaart Cf, Landewé RB. Gvozdenović E, et al. Scand J Rheumatol. 2014;43(5):349-55. doi: 10.3109/03009742.2014.887767. Epub 2014 Jun 5. Scand J Rheumatol. 2014. PMID: 24898046 Review.

4

Should rheumatoid factor in rheumatoid arthritis be sent to Davy Jones's Locker?

Besada E, Nikolaissen C, Nossent H. Besada E, et al. Scand J Rheumatol. 2012 Mar;41(2):85-8. doi: 10.3109/03009742.2011.617316. Epub 2012 Jan 3. Scand J Rheumatol. 2012. PMID: 22211313 Review.

5

Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort.

Gaujoux-Viala C, Paternotte S, Combe B, Dougados M. Gaujoux-Viala C, et al. Rheumatology (Oxford). 2012 Sep;51(9):1648-54. doi: 10.1093/rheumatology/kes135. Epub 2012 Jun 1. Rheumatology (Oxford). 2012. PMID: 22661552

6

Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital.

de Thurah A, Nørgaard M, Johansen M, Stengaard-Pedersen K. de Thurah A, et al. Scand J Rheumatol. 2010;39(1):19-25. doi: 10.3109/03009740903185987. Scand J Rheumatol. 2010. PMID: 20132066

7

A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.

Vastesaeger N, Xu S, Aletaha D, St Clair EW, Smolen JS. Vastesaeger N, et al. Rheumatology (Oxford). 2009 Sep;48(9):1114-21. doi: 10.1093/rheumatology/kep155. Epub 2009 Jul 9. Rheumatology (Oxford). 2009. PMID: 19589891 Review.

8

CD4(+)CD25(+) regulatory T cells as a therapeutic target in rheumatoid arthritis.

Yu Q, Xu M, Yu F, Jin Y. Yu Q, et al. Cent Eur J Immunol. 2014;39(1):100-3. doi: 10.5114/ceji.2014.42133. Epub 2014 Apr 17. Cent Eur J Immunol. 2014. PMID: 26155108 Free PMC article. Review.

9

Methotrexate treatment for rheumatoid arthritis in Poland: Retrospective analysis of patients in routine clinical practice.

Świerkot J, Batko B, Wiland P, Jędrzejewski M, Stajszczyk M. Świerkot J, et al. Reumatologia. 2018;56(1):3-9. doi: 10.5114/reum.2018.74741. Epub 2018 Feb 28. Reumatologia. 2018. PMID: 29686436 Free PMC article.

10

Ultrasound assessment for the rapid classification of early arthritis patients.

Tămaş MM, Rednic N, Felea I, Rednic S. Tămaş MM, et al. J Investig Med. 2013 Dec;61(8):1184-91. doi: 10.2310/JIM.0000000000000005. J Investig Med. 2013. PMID: 24113730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results